• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超氧化物歧化酶2改善Leber遗传性视神经病变患者皮肤成纤维细胞中的线粒体功能障碍。

Superoxide dismutase 2 ameliorates mitochondrial dysfunction in skin fibroblasts of Leber's hereditary optic neuropathy patients.

作者信息

Zhou Qingru, Yao Shun, Yang Mingzhu, Guo Qingge, Li Ya, Li Lei, Lei Bo

机构信息

Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China.

Henan Eye Hospital, Henan Provincial People's Hospital, Henan Eye Institute, Zhengzhou, China.

出版信息

Front Neurosci. 2022 Aug 9;16:917348. doi: 10.3389/fnins.2022.917348. eCollection 2022.

DOI:10.3389/fnins.2022.917348
PMID:36017189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9398213/
Abstract

BACKGROUND

In Leber's hereditary optic neuropathy (LHON), mtDNA mutations mediate mitochondrial dysfunction and apoptosis of retinal ganglion cells. Mitochondrial superoxide dismutase 2 (SOD2) is a crucial antioxidase against reactive oxygen species (ROS). This study aims to investigate whether SOD2 could ameliorate mtDNA mutation mediated mitochondrial dysfunction in skin fibroblasts of LHON patients and explore the underlying mechanisms.

METHODS

The skin of normal healthy subjects and severe LHON patients harboring m.11778G > A mutation was taken to prepare immortalized skin fibroblast cell lines (control-iFB and LHON-iFB). LHON-iFB cells were transfected with SOD2 plasmid or negative control plasmid, respectively. In addition, human neuroblastoma SH-SY5Y cells and human primary retinal pigmental epithelium (hRPE) cells were stimulated by HO after gene transfection. The oxygen consumption rate (OCR) was measured with a Seahorse extracellular flux analyzer. The level of ATP production, mitochondrial membrane potential, ROS and malondialdehyde (MDA) were measured separately with the corresponding assay kits. The expression level of SOD2, inflammatory cytokines and p-IκBα/IκBα was evaluated by western-blot. Assessment of apoptosis was performed by TUNEL assay.

RESULTS

LHON-iFB exhibited lower OCR, ATP production, mitochondrial membrane potential but higher level of ROS and MDA than control-iFB. Western-blot revealed a significantly increased expression of IL-6 and p-IκBα/IκBα in LHON-iFB. Compared with the negative control, SOD2 overexpression increased OCR, ATP production and elevated mitochondrial membrane potential, but impaired ROS and MDA production. Besides, western-blot demonstrated exogenous SOD2 reduced the protein level of IL-6 and p-IκBα/IκBα. TUNEL assays suggested SOD2 inhibited cells apoptosis. Analogously, in SH-SY5Y and hRPE cells, SOD2 overexpression increased ATP production and mitochondrial membrane potential, but decreased ROS, MDA levels and suppressed apoptosis.

CONCLUSION

SOD2 upregulation inhibited cells apoptosis through ameliorating mitochondrial dysfunction and reducing NF-κB associated inflammatory response. This study further support exogenous SOD2 may be a promising therapy for the treatment of LHON.

摘要

背景

在Leber遗传性视神经病变(LHON)中,线粒体DNA(mtDNA)突变介导视网膜神经节细胞的线粒体功能障碍和凋亡。线粒体超氧化物歧化酶2(SOD2)是对抗活性氧(ROS)的关键抗氧化酶。本研究旨在探讨SOD2是否能改善LHON患者皮肤成纤维细胞中mtDNA突变介导的线粒体功能障碍,并探索其潜在机制。

方法

采集正常健康受试者及携带m.11778G>A突变的严重LHON患者的皮肤,制备永生化皮肤成纤维细胞系(对照-iFB和LHON-iFB)。LHON-iFB细胞分别用SOD2质粒或阴性对照质粒转染。此外,基因转染后,用HO刺激人神经母细胞瘤SH-SY5Y细胞和人原代视网膜色素上皮(hRPE)细胞。用海马细胞外通量分析仪测量氧消耗率(OCR)。分别用相应的检测试剂盒测量ATP生成水平、线粒体膜电位、ROS和丙二醛(MDA)水平。通过蛋白质印迹法评估SOD2、炎性细胞因子和p-IκBα/IκBα的表达水平。通过TUNEL检测进行凋亡评估。

结果

与对照-iFB相比,LHON-iFB表现出较低的OCR、ATP生成、线粒体膜电位,但ROS和MDA水平较高。蛋白质印迹法显示LHON-iFB中IL-6和p-IκBα/IκBα的表达显著增加。与阴性对照相比,SOD2过表达增加了OCR、ATP生成并提高了线粒体膜电位,但降低了ROS和MDA生成。此外,蛋白质印迹法表明外源性SOD2降低了IL-6和p-IκBα/IκBα的蛋白水平。TUNEL检测表明SOD2抑制细胞凋亡。类似地,在SH-SY5Y和hRPE细胞中,SOD2过表达增加了ATP生成和线粒体膜电位,但降低了ROS、MDA水平并抑制了凋亡。

结论

SOD2上调通过改善线粒体功能障碍和减少NF-κB相关的炎症反应来抑制细胞凋亡。本研究进一步支持外源性SOD2可能是治疗LHON的一种有前景的疗法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc8c/9398213/d127fdfac451/fnins-16-917348-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc8c/9398213/0aa1a1e4cffa/fnins-16-917348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc8c/9398213/527e6d0d1c31/fnins-16-917348-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc8c/9398213/adda34ba7cfd/fnins-16-917348-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc8c/9398213/b583056c2358/fnins-16-917348-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc8c/9398213/d127fdfac451/fnins-16-917348-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc8c/9398213/0aa1a1e4cffa/fnins-16-917348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc8c/9398213/527e6d0d1c31/fnins-16-917348-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc8c/9398213/adda34ba7cfd/fnins-16-917348-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc8c/9398213/b583056c2358/fnins-16-917348-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc8c/9398213/d127fdfac451/fnins-16-917348-g005.jpg

相似文献

1
Superoxide dismutase 2 ameliorates mitochondrial dysfunction in skin fibroblasts of Leber's hereditary optic neuropathy patients.超氧化物歧化酶2改善Leber遗传性视神经病变患者皮肤成纤维细胞中的线粒体功能障碍。
Front Neurosci. 2022 Aug 9;16:917348. doi: 10.3389/fnins.2022.917348. eCollection 2022.
2
Optimized allotopic expression of mitochondrial ND6 transgene restored complex I and apoptosis deficiencies caused by LHON-linked ND6 14484T > C mutation.优化异位表达线粒体 ND6 转基因可恢复 LHON 相关 ND6 14484T > C 突变引起的复合物 I 和细胞凋亡缺陷。
J Biomed Sci. 2023 Aug 3;30(1):63. doi: 10.1186/s12929-023-00951-1.
3
Preservation of Mitochondrial Function by SkQ1 in Skin Fibroblasts Derived from Patients with Leber's Hereditary Optic Neuropathy Is Associated with the PINK1/PRKN-Mediated Mitophagy.SkQ1对Leber遗传性视神经病变患者来源的皮肤成纤维细胞线粒体功能的保护作用与PINK1/PRKN介导的线粒体自噬相关。
Biomedicines. 2024 Sep 4;12(9):2020. doi: 10.3390/biomedicines12092020.
4
Optic neuropathy induced by reductions in mitochondrial superoxide dismutase.线粒体超氧化物歧化酶减少所致的视神经病变
Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1088-96. doi: 10.1167/iovs.02-0864.
5
Multi-mtDNA Variants May Be a Factor Contributing to Mitochondrial Function Variety in the Skin-Derived Fibroblasts of Leber's Hereditary Optic Neuropathy Patients.多个线粒体DNA变异可能是导致Leber遗传性视神经病变患者皮肤来源成纤维细胞线粒体功能多样性的一个因素。
Front Mol Neurosci. 2022 Jul 13;15:920221. doi: 10.3389/fnmol.2022.920221. eCollection 2022.
6
Identification of novel mitochondrial mutations in Leber's hereditary optic neuropathy.Leber遗传性视神经病变中新型线粒体突变的鉴定。
Mol Vis. 2010 Apr 30;16:782-92.
7
Complex I mutations synergize to worsen the phenotypic expression of Leber's hereditary optic neuropathy.复合体 I 突变协同作用,使莱伯遗传性视神经病变的表型表达恶化。
J Biol Chem. 2020 Sep 18;295(38):13224-13238. doi: 10.1074/jbc.RA120.014603. Epub 2020 Jul 28.
8
Profiling the mitochondrial proteome of Leber's Hereditary Optic Neuropathy (LHON) in Thailand: down-regulation of bioenergetics and mitochondrial protein quality control pathways in fibroblasts with the 11778G>A mutation.泰国莱伯遗传性视神经病变(LHON)线粒体蛋白质组分析:11778G>A突变的成纤维细胞中生物能量学和线粒体蛋白质质量控制途径的下调
PLoS One. 2014 Sep 12;9(9):e106779. doi: 10.1371/journal.pone.0106779. eCollection 2014.
9
The exome sequencing identified the mutation in YARS2 encoding the mitochondrial tyrosyl-tRNA synthetase as a nuclear modifier for the phenotypic manifestation of Leber's hereditary optic neuropathy-associated mitochondrial DNA mutation.外显子组测序确定,编码线粒体酪氨酸-tRNA合成酶的YARS2中的突变是与Leber遗传性视神经病变相关的线粒体DNA突变表型表现的核修饰因子。
Hum Mol Genet. 2016 Feb 1;25(3):584-96. doi: 10.1093/hmg/ddv498. Epub 2015 Dec 8.
10
Contribution of mitochondrial ND1 3394T>C mutation to the phenotypic manifestation of Leber's hereditary optic neuropathy.线粒体 ND1 3394T>C 突变对 Leber 遗传性视神经病变表型表现的贡献。
Hum Mol Genet. 2019 May 1;28(9):1515-1529. doi: 10.1093/hmg/ddy450.

引用本文的文献

1
Technological advances in the diagnosis and management of inherited optic neuropathies.遗传性视神经病变诊断与管理的技术进展
Front Neurol. 2025 Jul 25;16:1609033. doi: 10.3389/fneur.2025.1609033. eCollection 2025.
2
Beyond Paradox: Ozone Therapy as a Hormetic Modulator in Ischemia-Reperfusion Injury - An Update.超越悖论:臭氧疗法作为缺血再灌注损伤中的一种促适应性调节剂——最新进展
Cell Biochem Biophys. 2025 Jul 10. doi: 10.1007/s12013-025-01824-0.
3
Targeting oxidative stress in diabetic retinopathy: mechanisms, pathology, and novel treatment approaches.

本文引用的文献

1
Multi-mtDNA Variants May Be a Factor Contributing to Mitochondrial Function Variety in the Skin-Derived Fibroblasts of Leber's Hereditary Optic Neuropathy Patients.多个线粒体DNA变异可能是导致Leber遗传性视神经病变患者皮肤来源成纤维细胞线粒体功能多样性的一个因素。
Front Mol Neurosci. 2022 Jul 13;15:920221. doi: 10.3389/fnmol.2022.920221. eCollection 2022.
2
The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.利用成纤维细胞作为研究神经紊乱中线粒体损伤的有价值策略。
Transl Neurodegener. 2022 Jul 4;11(1):36. doi: 10.1186/s40035-022-00308-y.
3
Identification of Age-associated Proteins and Functional Alterations in Human Retinal Pigment Epithelium.
针对糖尿病视网膜病变中的氧化应激:机制、病理学及新的治疗方法
Front Immunol. 2025 Jun 16;16:1571576. doi: 10.3389/fimmu.2025.1571576. eCollection 2025.
4
Exploring the Phenotypic Heterogeneity and Bioenergetic Profile of the m.13513G>A mtDNA Substitution: A Heteroplasmy Perspective.探索m.13513G>A线粒体DNA替代的表型异质性和生物能量特征:异质性视角
Int J Mol Sci. 2025 May 10;26(10):4565. doi: 10.3390/ijms26104565.
5
Atypical Leber Hereditary Optic Neuropathy (LHON) Associated with a Novel MT-CYB:m.15309T>C(Ile188Thr) Variant.与新型MT-CYB:m.15309T>C(Ile188Thr)变异相关的非典型Leber遗传性视神经病变(LHON)
Genes (Basel). 2025 Jan 20;16(1):108. doi: 10.3390/genes16010108.
6
Preservation of Mitochondrial Function by SkQ1 in Skin Fibroblasts Derived from Patients with Leber's Hereditary Optic Neuropathy Is Associated with the PINK1/PRKN-Mediated Mitophagy.SkQ1对Leber遗传性视神经病变患者来源的皮肤成纤维细胞线粒体功能的保护作用与PINK1/PRKN介导的线粒体自噬相关。
Biomedicines. 2024 Sep 4;12(9):2020. doi: 10.3390/biomedicines12092020.
7
Pathogenicity and Function Analysis of Two Novel SLC4A11 Variants in Patients With Congenital Hereditary Endothelial Dystrophy.两个新的 SLC4A11 变异体在先天性遗传性血管内皮营养不良患者中的致病性和功能分析。
Transl Vis Sci Technol. 2023 Oct 3;12(10):1. doi: 10.1167/tvst.12.10.1.
8
Case Report: Abnormalities of sperm motility and morphology in a patient with Leber hereditary optic neuropathy: Improvement after idebenone therapy.病例报告:一名患有Leber遗传性视神经病变患者的精子活力和形态异常:艾地苯醌治疗后的改善
Front Neurol. 2023 Jan 4;13:946559. doi: 10.3389/fneur.2022.946559. eCollection 2022.
鉴定与人眼视网膜色素上皮细胞衰老相关的蛋白及功能变化。
Genomics Proteomics Bioinformatics. 2022 Aug;20(4):633-647. doi: 10.1016/j.gpb.2022.06.001. Epub 2022 Jun 23.
4
Creating Cell Model 2.0 Using Patient Samples Carrying a Pathogenic Mitochondrial DNA Mutation: iPSC Approach for LHON.使用携带致病性线粒体 DNA 突变的患者样本创建细胞模型 2.0:LHON 的 iPSC 方法。
Methods Mol Biol. 2022;2549:219-231. doi: 10.1007/7651_2021_384.
5
Induced Pluripotent Stem Cells for Inherited Optic Neuropathies-Disease Modeling and Therapeutic Development.用于遗传性视神经病变的诱导多能干细胞——疾病建模与治疗开发
J Neuroophthalmol. 2022 Mar 1;42(1):35-44. doi: 10.1097/WNO.0000000000001375. Epub 2021 Sep 30.
6
Exploiting hiPSCs in Leber's Hereditary Optic Neuropathy (LHON): Present Achievements and Future Perspectives.诱导多能干细胞在Leber遗传性视神经病变(LHON)中的应用:当前成果与未来展望
Front Neurol. 2021 Jun 8;12:648916. doi: 10.3389/fneur.2021.648916. eCollection 2021.
7
Mitochondriopathies as a Clue to Systemic Disorders-Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine.线粒体病作为全身性疾病的线索——预测、预防和个体化(3P)医学中分析工具和缓解措施。
Int J Mol Sci. 2021 Feb 18;22(4):2007. doi: 10.3390/ijms22042007.
8
Strategies to expand the therapeutic potential of superoxide dismutase by exploiting delivery approaches.利用递送方法拓展超氧化物歧化酶治疗潜力的策略。
Int J Biol Macromol. 2021 Jan 31;168:846-865. doi: 10.1016/j.ijbiomac.2020.11.149. Epub 2020 Nov 23.
9
The Protective Effects of VVN001 on LPS-Induced Inflammatory Responses in Human RPE Cells and in a Mouse Model of EIU.VVN001 对 LPS 诱导的人 RPE 细胞炎症反应和 EIU 小鼠模型的保护作用。
Inflammation. 2021 Apr;44(2):780-794. doi: 10.1007/s10753-020-01377-9. Epub 2020 Nov 16.
10
Oxidative Stress Profile in Genetically Confirmed Cases of Leber's Hereditary Optic Neuropathy.遗传性视神经病变的基因确诊病例中的氧化应激特征。
J Mol Neurosci. 2021 May;71(5):1070-1081. doi: 10.1007/s12031-020-01729-y. Epub 2020 Oct 23.